AORT insider James Mackin files Form 144 to sell 30,921 shares

Rhea-AI Filing Summary

James Mackin filed a Form 144 notice to sell 30,921 common shares of the issuer through Fidelity Brokerage Services LLC on the NYSE, with 47,374,939 shares outstanding. The shares relate to an option originally granted on 03/05/2019 and acquired on 12/03/2025, with the purchase price paid in cash on the same date. In the past three months, Mackin has sold additional common shares in three transactions, totaling 17,580 shares for gross proceeds of $784,400.26, 34,210 shares for $1,568,812.44, and 30,921 shares for $1,408,736.02. By signing the notice, the seller represents that he is not aware of any undisclosed material adverse information about the issuer’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	30921	1405695.03	47374939	12/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/03/2025	Option Granted - 03/05/2019	Issuer			30921	12/03/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Mackin 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/10/2025	17580	784400.26
James Mackin 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/13/2025	34210	1568812.44
James Mackin 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	12/02/2025	30921	1408736.02

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for AORT disclose about James Mackin?

The filing shows that James Mackin has filed a notice under Rule 144 to sell 30,921 common shares of the issuer through Fidelity Brokerage Services LLC on the NYSE, with the planned sale date listed as 12/03/2025.

How many AORT shares did James Mackin sell in the past three months?

Over the past three months, James Mackin sold 17,580 common shares on 11/10/2025, 34,210 shares on 11/13/2025, and 30,921 shares on 12/02/2025, as disclosed in the Form 144.

What were the gross proceeds from James Mackin’s recent AORT share sales?

The filing reports gross proceeds of $784,400.26 from the 11/10/2025 sale, $1,568,812.44 from the 11/13/2025 sale, and $1,408,736.02 from the 12/02/2025 sale of common shares.

How many AORT shares are outstanding according to this Form 144?

The Form 144 states that there are 47,374,939 common shares outstanding for the issuer at the time of the notice.

How did James Mackin acquire the AORT shares being sold under this Form 144?

The filing explains that the 30,921 common shares to be sold were acquired from the issuer via an option granted on 03/05/2019, with the shares acquired on 12/03/2025 and paid for in cash on that date.

What representation does the seller make in this AORT Form 144 filing?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.